SNY
Income statement / Annual
Last year (2024), Sanofi's total revenue was $44.29 B,
a decrease of 3.80% from the previous year.
In 2024, Sanofi's net income was $5.56 B.
See Sanofi,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$44.29 B |
$46.03 B |
$45.39 B |
$39.18 B |
$37.37 B |
$37.63 B |
$35.68 B |
$36.22 B |
$34.70 B |
$34.86 B |
| Cost of Revenue |
$13.21 B
|
$14.24 B
|
$13.69 B
|
$12.26 B
|
$12.16 B
|
$11.98 B
|
$11.32 B
|
$11.45 B
|
$10.70 B
|
$10.92 B
|
| Gross Profit |
$31.08 B
|
$31.80 B
|
$31.70 B
|
$26.92 B
|
$25.21 B
|
$25.66 B
|
$24.36 B
|
$24.77 B
|
$24.00 B
|
$23.94 B
|
| Gross Profit Ratio |
0.7
|
0.69
|
0.7
|
0.69
|
0.67
|
0.68
|
0.68
|
0.68
|
0.69
|
0.69
|
| Research and Development Expenses |
$7.39 B
|
$6.73 B
|
$6.71 B
|
$5.69 B
|
$5.53 B
|
$6.02 B
|
$6.35 B
|
$5.57 B
|
$5.23 B
|
$5.08 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$75.00 M
|
$106.00 M
|
$106.00 M
|
$114.00 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$9.39 B
|
$9.88 B
|
$9.86 B
|
$10.06 B
|
$9.49 B
|
$9.38 B
|
| Selling, General & Administrative Expenses |
$9.18 B
|
$10.77 B
|
$10.54 B
|
$9.56 B
|
$9.39 B
|
$9.88 B
|
$9.93 B
|
$10.16 B
|
$9.59 B
|
$9.50 B
|
| Other Expenses |
$7.25 B
|
$6.45 B
|
$2.57 B
|
$2.53 B
|
$2.40 B
|
$2.53 B
|
$1.70 B
|
$1.66 B
|
$1.65 B
|
$2.23 B
|
| Operating Expenses |
$23.83 B
|
$23.94 B
|
$19.81 B
|
$17.77 B
|
$17.32 B
|
$18.43 B
|
$17.99 B
|
$17.39 B
|
$16.48 B
|
$16.81 B
|
| Cost And Expenses |
$37.03 B
|
$38.16 B
|
-$7.29 B
|
$30.03 B
|
$29.48 B
|
$30.41 B
|
-$7.73 B
|
-$7.42 B
|
-$7.18 B
|
-$7.44 B
|
| Interest Income |
$413.00 M
|
$546.00 M
|
$206.00 M
|
$40.00 M
|
$53.00 M
|
$141.00 M
|
$164.00 M
|
$147.00 M
|
$68.00 M
|
$178.00 M
|
| Interest Expense |
$749.00 M
|
$1.09 B
|
$461.00 M
|
$368.00 M
|
$390.00 M
|
$444.00 M
|
$495.00 M
|
$420.00 M
|
$924.00 M
|
$559.00 M
|
| Depreciation & Amortization |
$3.59 B
|
$3.78 B
|
$3.70 B
|
$3.13 B
|
$3.27 B
|
$3.75 B
|
$3.46 B
|
$3.15 B
|
$2.99 B
|
-$2.48 B
|
| EBITDA |
$11.03 B |
$12.00 B |
$14.06 B |
$11.29 B |
$17.51 B |
$7.11 B |
$9.36 B |
$10.28 B |
$10.36 B |
$10.23 B |
| EBITDA Ratio |
0.25
|
0.26
|
0.31
|
0.27
|
0.26
|
0.26
|
0.26
|
0.28
|
0.3
|
0.29
|
| Operating Income Ratio |
0.16
|
0.17
|
0.37
|
0.21
|
0.22
|
0.2
|
0.35
|
0.33
|
0.36
|
0.36
|
| Total Other Income/Expenses Net |
-$554.00 M
|
-$722.00 M
|
-$166.00 M
|
-$328.00 M
|
$24.00 M
|
-$229.00 M
|
$228.00 M
|
-$188.00 M
|
-$720.00 M
|
-$403.00 M
|
| Income Before Tax |
$6.70 B
|
$7.15 B
|
$10.49 B
|
$7.80 B
|
$13.80 B
|
$2.82 B
|
$4.90 B
|
$5.62 B
|
$5.81 B
|
$5.22 B
|
| Income Before Tax Ratio |
0.15
|
0.16
|
0.23
|
0.2
|
0.37
|
0.07
|
0.14
|
0.16
|
0.17
|
0.15
|
| Income Tax Expense |
$1.20 B
|
$1.60 B
|
$2.01 B
|
$1.56 B
|
$1.81 B
|
$139.00 M
|
$481.00 M
|
$1.72 B
|
$1.33 B
|
$709.00 M
|
| Net Income |
$5.56 B
|
$5.40 B
|
$8.37 B
|
$6.22 B
|
$12.29 B
|
$2.81 B
|
$4.31 B
|
$3.89 B
|
$4.71 B
|
$4.29 B
|
| Net Income Ratio |
0.13
|
0.12
|
0.18
|
0.16
|
0.33
|
0.07
|
0.12
|
0.11
|
0.14
|
0.12
|
| EPS |
4.44 |
4.31 |
6.69 |
4.97 |
9.81 |
2.33 |
3.45 |
3.08 |
3.42 |
3.38 |
| EPS Diluted |
4.44 |
4.3 |
6.66 |
4.95 |
9.76 |
2.31 |
3.43 |
3.07 |
3.39 |
3.34 |
| Weighted Average Shares Out |
$1.25 B
|
$1.25 B
|
$1.25 B
|
$1.25 B
|
$1.25 B
|
$1.25 B
|
$1.25 B
|
$1.27 B
|
$1.29 B
|
$1.32 B
|
| Weighted Average Shares Out Diluted |
$1.25 B
|
$1.26 B
|
$1.26 B
|
$1.26 B
|
$1.26 B
|
$1.26 B
|
$1.26 B
|
$1.27 B
|
$1.30 B
|
$1.32 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
